| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/17/2009 | WO2009152209A2 Combined visual/fluorescence analyte detection test |
| 12/17/2009 | WO2009152183A2 System and method for hybridization slide processing |
| 12/17/2009 | WO2009152164A2 Smoking cessation kit and method |
| 12/17/2009 | WO2009152040A1 Auto-calibration circuit or label and method of forming the same |
| 12/17/2009 | WO2009151967A1 Metabolic biomarkers for ovarian cancer and methods of use thereof |
| 12/17/2009 | WO2009151908A1 Biomarkers for egfr/her/erbb drug efficacy |
| 12/17/2009 | WO2009151697A2 Compositions and processes relating to human bocavirus |
| 12/17/2009 | WO2009151693A2 Imaging mass spectrometry for improved prostate cancer diagnostics |
| 12/17/2009 | WO2009151633A1 Novel monoclonal antibodies against hpv proteins |
| 12/17/2009 | WO2009151632A1 Detection of early stages and late stages hpv infection |
| 12/17/2009 | WO2009151618A2 Methods and compositions for treating alzheimer's disease |
| 12/17/2009 | WO2009151610A2 Flow cytometer apparatus for three dimensional diffraction imaging and related methods |
| 12/17/2009 | WO2009151542A2 Nicotinic acid receptor ligands |
| 12/17/2009 | WO2009151541A1 Brown adipocyte progenitors in human skeletal muscle |
| 12/17/2009 | WO2009151511A1 Systems and methods for identifying combinations of compounds of therapeutic interest |
| 12/17/2009 | WO2009151487A1 Methods of assaying vaccine potency |
| 12/17/2009 | WO2009151390A1 Products and analytical method |
| 12/17/2009 | WO2009151346A1 A method for determining bacterial antibiotic resistance or bacterial susceptibility, a diagnostic kit for the detection of the antibiotic resistance and use of such diagnostic kit |
| 12/17/2009 | WO2009151324A1 Model system for diagnosing lipid metabolism |
| 12/17/2009 | WO2009151313A1 A novel antiviral peptide against avian influenza virus h9n2 |
| 12/17/2009 | WO2009151150A1 Method for detecting or quantifying dna |
| 12/17/2009 | WO2009151149A1 Method for detecting or quantifying dna |
| 12/17/2009 | WO2009151148A1 Composite particle, method for producing the same, dispersion solution, magnetic biosensing apparatus and magnetic biosensing method |
| 12/17/2009 | WO2009151091A1 Method for examination of alzheimer’s disease |
| 12/17/2009 | WO2009151058A1 Analyzer using magnetic particles |
| 12/17/2009 | WO2009150883A1 Skin-substitutive membrane, metal mold, and method of evaluating agent for external application onto skin |
| 12/17/2009 | WO2009150879A1 Semiconductor nanoparticle phosphor |
| 12/17/2009 | WO2009150839A1 Diagnosis/treatment option for head-and-neck tumor using micro-rna as biomarker |
| 12/17/2009 | WO2009150753A1 Blood coagulation reaction inhibitor |
| 12/17/2009 | WO2009150595A1 Parathyroid hormone assay |
| 12/17/2009 | WO2009150550A2 Genetic component of complications in type 2 diabetes |
| 12/17/2009 | WO2009150540A2 Sample control for improved sensitivity and clear down times for a membrane based ims |
| 12/17/2009 | WO2009150533A2 Analysis of vi saccharides |
| 12/17/2009 | WO2009150513A2 Protein |
| 12/17/2009 | WO2009150422A1 Biomarkers for lupus |
| 12/17/2009 | WO2009150327A2 Method for determining hemoglobin rate, as well as for enumerating and differentiating leukocytes, and suitable medium |
| 12/17/2009 | WO2009150295A1 Detection of cannabis use |
| 12/17/2009 | WO2009150256A1 Markers for predicting response and survival in anti-egfr treated patients |
| 12/17/2009 | WO2009150255A2 Markers for predicting response and survival in anti-egfr treated patients |
| 12/17/2009 | WO2009150253A1 Assessment of complications of patients with type 1 diabetes |
| 12/17/2009 | WO2009150229A1 Tet2 as a new diagnostic and pronostic marker in hematopoietic neoplasms |
| 12/17/2009 | WO2009150181A2 H-fabp as a marker for myocardial hibernation |
| 12/17/2009 | WO2009150172A1 Blood serum marker for detection and diagnosis of alzheimer's disease |
| 12/17/2009 | WO2009149871A1 High throughput method for analyzing the fatty acid composition in plasma phosphoglycerides |
| 12/17/2009 | WO2009149852A1 Method for detection of stromal epitopes |
| 12/17/2009 | WO2009149714A1 Selection of colorectal cancer patients for neo-adjuvant and adjuvant systemic anti-cancer treatment |
| 12/17/2009 | WO2009149615A1 A method of quickly determining human abo/rh/mn blood type and a test kit thereof |
| 12/17/2009 | WO2009149577A1 Methods of identifying modulators of the bitter taste receptor tas2r44 |
| 12/17/2009 | WO2009134917A3 Methods for treating inflammation |
| 12/17/2009 | WO2009132130A3 Methods of identifying anti-inflammatory compounds |
| 12/17/2009 | WO2009132058A3 Levels of bcma protein expression on b cells and use in diagnostic methods |
| 12/17/2009 | WO2009131963A3 Method and kit for assessing the suitability of erythrocytes for transfusion |
| 12/17/2009 | WO2009130659A3 Plasma membrane vesicles and methods of making and using same |
| 12/17/2009 | WO2009130649A3 Plasma membrane vesicles and methods of making and using same |
| 12/17/2009 | WO2009125219A3 Markers of oocyte viability |
| 12/17/2009 | WO2009122444A3 Method for the diagnosis of higher- and lower-grade astrocytoma using biomarkers and diagnostic kit thereof |
| 12/17/2009 | WO2009121152A3 Gene signatures |
| 12/17/2009 | WO2009121041A3 Paper-based microfluidic systems |
| 12/17/2009 | WO2009121037A3 Three-dimensional microfluidic devices |
| 12/17/2009 | WO2009117823A8 Continuous measurement of amine loading in gas processing plants using raman spectroscopy |
| 12/17/2009 | WO2009117664A3 Method and apparatus for determining red blood cell indices of a blood sample utilizing the intrinsic pigmentation of hemoglobin contained within the red blood cells |
| 12/17/2009 | WO2009112038A3 A microfluidic system and a method of performing a test |
| 12/17/2009 | WO2009111033A3 Detection of biomarkers and biomarker complexes |
| 12/17/2009 | WO2009101181A3 Plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells |
| 12/17/2009 | WO2009085473A4 Genome identification system |
| 12/17/2009 | WO2009067546A3 Lung cancer markers and uses thereof |
| 12/17/2009 | WO2009056633A3 Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (tnf) treatment |
| 12/17/2009 | WO2009055382A8 One-step immunoassays exhibiting increased sensitivity and specificity |
| 12/17/2009 | WO2008030282A3 Recombinant vaccine against bluetongue virus |
| 12/17/2009 | US20090313710 Nonalcoholic Steatohepatitis Model Animal and Fatty Liver Model Animal |
| 12/17/2009 | US20090313709 Genetically Modified Animal and Use Thereof |
| 12/17/2009 | US20090313708 Gpr22 and methods relating thereto |
| 12/17/2009 | US20090313707 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 12/17/2009 | US20090313189 Method, system and apparatus for assembling and using biological knowledge |
| 12/17/2009 | US20090312671 Evaluating system of masticatory efficiency and artificial food material |
| 12/17/2009 | US20090312612 Method, system and apparatus for monitoring patients |
| 12/17/2009 | US20090312596 Assay and kit for predicting implantation success in assisted fertilisation |
| 12/17/2009 | US20090312533 Single copy genomic hybridization probes and method of generating same |
| 12/17/2009 | US20090312415 Remedy/preventive for vascular disorders and hypertension and method of screening the same |
| 12/17/2009 | US20090312411 Preventing or reducing risk of miscarriages |
| 12/17/2009 | US20090312410 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof |
| 12/17/2009 | US20090312394 Protection against and treatment of age related macular degeneration |
| 12/17/2009 | US20090312391 Unifying mechanism and methods to prevent cancer and neurodegenerative diseases |
| 12/17/2009 | US20090312345 Pharmacological chaperones for treating obesity |
| 12/17/2009 | US20090312298 Methods and Compositions Related to GABA Receptor Subunits |
| 12/17/2009 | US20090312258 Uses of human zven proteins and polynucleotides |
| 12/17/2009 | US20090312257 Uses of human zven proteins and polynucleotides |
| 12/17/2009 | US20090312256 Uses of human zven proteins and polynucleotides |
| 12/17/2009 | US20090312253 Methods of effecting Wnt signaling through Dkk structural analysis |
| 12/17/2009 | US20090312247 Natriuretic peptide related fragment in cardiovascular disease |
| 12/17/2009 | US20090312245 SRA binding protein |
| 12/17/2009 | US20090312244 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 12/17/2009 | US20090312238 Protection Against Oxidative Damage in Cells |
| 12/17/2009 | US20090312191 Method and system for the detection of atypical sequences via generalized compositional methods |
| 12/17/2009 | US20090311806 target substance capturing body comprising a substrate and a protein utilizing an anti-gold antibody and a gold-binding side which is a part of the anti-gold antibody; used for the detection of a target substance |
| 12/17/2009 | US20090311805 Assay device and method |
| 12/17/2009 | US20090311804 Magnetic bead assisted sample conditioning system |
| 12/17/2009 | US20090311803 Treatment Of Tumors Expressing Mutant EGF Receptors |
| 12/17/2009 | US20090311802 Isolated Soluble IL-TIF/IL-22 Receptor or Binding Protein Which Binds to IL-TIF/IL-22 and Uses Thereof |
| 12/17/2009 | US20090311801 Diagnostic Test to Exclude Significant Renal Injury |